DIANNE OKONSKY: Open Payments
NPI 1881674505 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,917 in 144 payments from 50 companies in 2025. Trend: 2023 $2,625 · 2024 $2,683 · 2025 $2,917
Food & beverage: $2,917
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $225 |
| Regeneron Healthcare Solutions, Inc. | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 9 | $142 |
| Incyte Corporation | 6 | $142 |
| Celgene Corporation | 6 | $140 |
| BeOne Medicines USA, Inc. | 6 | $127 |
| Merck Sharp & Dohme LLC | 6 | $127 |
| Genentech USA, Inc. | 7 | $125 |
| GENZYME CORPORATION | 4 | $99 |
| Daiichi Sankyo Inc. | 4 | $94 |
Products named: LIBTAYO, REBLOZYL, KEYTRUDA, BRUKINSA, KISQALI, ENHERTU, MONJUVI, MONOFERRIC.
Industry payments across FL — which companies pay providers there.
